Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients

被引:190
作者
Lutsar, I [1 ]
Roffey, S [1 ]
Troke, P [1 ]
机构
[1] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England
关键词
D O I
10.1086/377131
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We characterized voriconazole concentrations in the cerebrospinal fluid (CSF) of immunocompetent guinea pigs and patients with invasive fungal infections. In animals, after receipt of oral doses of 4 or 10 mg/kg every 8 h, the mean ratios of CSF to plasma total and free drug concentration were 0.68 and 1.3, respectively. In humans, 1-10 h after receipt of voriconazole, the CSF concentrations ranged from 0.08 to 3.93 mg/mL, and the ratio of CSF to plasma concentration ranged from 0.22 to 1.0 ( median, 0.46).
引用
收藏
页码:728 / 732
页数:5
相关论文
共 23 条
  • [1] Transporting therapeutics across the blood-brain barrier
    Abbott, NJ
    Romero, IA
    [J]. MOLECULAR MEDICINE TODAY, 1996, 2 (03): : 106 - 113
  • [2] Pharmacokinetics and pharmacodynamics of antibiotics in meningitis
    Andes, DR
    Craig, WA
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1999, 13 (03) : 595 - +
  • [3] FLUCONAZOLE PENETRATION INTO CEREBROSPINAL-FLUID - IMPLICATIONS FOR TREATING FUNGAL-INFECTIONS OF THE CENTRAL NERVOUS-SYSTEM
    ARNDT, CAS
    WALSH, TJ
    MCCULLY, CL
    BALIS, FM
    PIZZO, PA
    POPLACK, DG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) : 178 - 180
  • [4] COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407
  • [5] Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
    Denning, DW
    Ribaud, P
    Milpied, N
    Caillot, D
    Herbrecht, R
    Thiel, E
    Haas, A
    Ruhnke, M
    Lode, H
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) : 563 - 571
  • [6] In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature
    Espinel-Ingroff, A
    Boyle, K
    Sheehan, DJ
    [J]. MYCOPATHOLOGIA, 2001, 150 (03) : 101 - 115
  • [7] Ghannoum MA, 2002, EUR J MED RES, V7, P242
  • [8] Fungal meningitis
    Gottfredsson, M
    Perfect, JR
    [J]. SEMINARS IN NEUROLOGY, 2000, 20 (03) : 307 - 322
  • [9] JAFRI HS, 1994, ANTIMICROB AGENTS CH, V38, P83
  • [10] Aspergillosis case - Fatality rate: Systematic review of the literature
    Lin, SJ
    Schranz, J
    Teutsch, SM
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 358 - 366